Historical milestones

Dated milestones that shaped cancer care and understanding, with their limits and what came next.

Every page here follows one idea: what happened, why it matters, and what it does not mean. Educational only — not medical advice.

• Breast cancer · 1998Trastuzumab is approved for HER2-positive breast cancerA dated cancer milestone (1998): an early triumph of targeted therapy. Why it mattered, its limits, and how the field evolved.
• Cervical cancer · 2020The World Health Organization sets a cervical-cancer elimination goalA dated cancer milestone (2020): a global strategy built on vaccination and screening. Why it mattered, its limits, and how the field evolved.
• Lung cancer · 1964The U.S. Surgeon General's report on smoking and healthA dated cancer milestone (1964): a turning point in public understanding of tobacco harm. Why it mattered, its limits, and how the field evolved.
• Cancer · 1971The U.S. National Cancer Act is signedA dated cancer milestone (1971): legislation that expanded federal cancer research, sometimes called the War on Cancer. Why it mattered, its limits, and how the field evolved.
• Cancer · 2016The U.S. Cancer Moonshot is announcedA dated cancer milestone (2016): a national push to accelerate cancer research and prevention. Why it mattered, its limits, and how the field evolved.
• Childhood cancer · 1986The retinoblastoma (RB) tumor-suppressor gene is clonedA dated cancer milestone (1986): the first tumor-suppressor gene isolated. Why it mattered, its limits, and how the field evolved.
• Leukemia · 1960The Philadelphia chromosome is identifiedA dated cancer milestone (1960): the first consistent chromosomal abnormality tied to a cancer. Why it mattered, its limits, and how the field evolved.
• Breast cancer · 2004The Oncotype DX recurrence-score test is introducedA dated cancer milestone (2004): genomic testing to guide chemotherapy decisions. Why it mattered, its limits, and how the field evolved.
• Cancer · 1937The National Cancer Institute is establishedA dated cancer milestone (1937): the U.S. federal center for cancer research and information. Why it mattered, its limits, and how the field evolved.
• Colorectal cancer · 2014The multi-target stool DNA test reaches patientsA dated cancer milestone (2014): a noninvasive option in colorectal-cancer screening. Why it mattered, its limits, and how the field evolved.
• Cancer · 2003The Human Genome Project is completedA dated cancer milestone (2003): a foundation for cancer genomics. Why it mattered, its limits, and how the field evolved.
• Cancer · 2017The first tissue-agnostic cancer drug approvalA dated cancer milestone (2017): treatment chosen by a tumor's biomarker rather than its location. Why it mattered, its limits, and how the field evolved.
• Prostate cancer · 2010The first therapeutic cancer vaccine is approvedA dated cancer milestone (2010): an immune therapy tailored to prostate cancer. Why it mattered, its limits, and how the field evolved.
• Lung cancer · 2016The first liquid-biopsy test for tumor DNA gains approvalA dated cancer milestone (2016): detecting cancer mutations from a blood sample. Why it mattered, its limits, and how the field evolved.
• Cervical cancer · 2006The first HPV vaccine is approvedA dated cancer milestone (2006): a vaccine that prevents infections causing several cancers. Why it mattered, its limits, and how the field evolved.
• Leukemia · 2017The first CAR T-cell therapy is approvedA dated cancer milestone (2017): engineered immune cells enter routine care for some blood cancers. Why it mattered, its limits, and how the field evolved.
• Lung cancer · 2009The Family Smoking Prevention and Tobacco Control ActA dated cancer milestone (2009): gave the FDA authority to regulate tobacco products. Why it mattered, its limits, and how the field evolved.
• Cancer · 2006The Cancer Genome Atlas launchesA dated cancer milestone (2006): a large effort to map the molecular changes in many cancers. Why it mattered, its limits, and how the field evolved.
• Breast cancer · 1995The BRCA2 gene is identifiedA dated cancer milestone (1995): the second major hereditary breast-cancer gene. Why it mattered, its limits, and how the field evolved.
• Breast cancer · 1994The BRCA1 gene is clonedA dated cancer milestone (1994): enabled genetic testing for hereditary breast and ovarian cancer. Why it mattered, its limits, and how the field evolved.
• Childhood cancer · 1948Sidney Farber induces remission in childhood leukemia with aminopterinA dated cancer milestone (1948): an early demonstration that chemotherapy could work. Why it mattered, its limits, and how the field evolved.
• Sarcoma · 1966Peyton Rous is awarded the Nobel Prize for tumor virusesA dated cancer milestone (1966): recognition decades after his discovery of a cancer-causing virus. Why it mattered, its limits, and how the field evolved.
• Breast cancer · 1990Mary-Claire King maps BRCA1 to chromosome 17A dated cancer milestone (1990): evidence for an inherited breast-cancer gene. Why it mattered, its limits, and how the field evolved.
• Lung cancer · 2011Low-dose CT screening is shown to reduce lung-cancer deathsA dated cancer milestone (2011): evidence that reshaped lung-cancer screening. Why it mattered, its limits, and how the field evolved.
• Cancer · 1971Judah Folkman proposes tumor angiogenesisA dated cancer milestone (1971): the idea that tumors recruit blood vessels, later a drug target. Why it mattered, its limits, and how the field evolved.
• Cancer · 2018James Allison and Tasuku Honjo win the Nobel Prize for checkpoint therapyA dated cancer milestone (2018): recognition of the science behind immune checkpoint inhibitors. Why it mattered, its limits, and how the field evolved.
• Melanoma · 2010Ipilimumab shows a survival benefit in melanomaA dated cancer milestone (2010): the first checkpoint inhibitor to extend survival in a cancer. Why it mattered, its limits, and how the field evolved.
• Leukemia · 2001Imatinib transforms chronic myeloid leukemiaA dated cancer milestone (2001): a targeted drug that turned a fatal leukemia into a manageable condition for many. Why it mattered, its limits, and how the field evolved.
• Breast cancer · 1998Herceptin's companion diagnostic ushers in precision oncologyA dated cancer milestone (1998): treatment guided by a tumor's molecular features. Why it mattered, its limits, and how the field evolved.
• Cervical cancer · 1983Harald zur Hausen links HPV to cervical cancerA dated cancer milestone (1983): the discovery behind cervical-cancer screening and vaccination. Why it mattered, its limits, and how the field evolved.
• Cancer · 2000Hanahan and Weinberg publish 'The Hallmarks of Cancer'A dated cancer milestone (2000): an influential framework for shared features of cancers. Why it mattered, its limits, and how the field evolved.
• Leukemia · 2001Gleevec appears on the cover of TIME magazineA dated cancer milestone (2001): a cultural marker of the arrival of targeted therapy. Why it mattered, its limits, and how the field evolved.
• Cervical cancer · 2014Gardasil 9 broadens HPV vaccine protectionA dated cancer milestone (2014): coverage against more cancer-causing HPV types. Why it mattered, its limits, and how the field evolved.
• Leukemia · 1990E. Donnall Thomas advances bone-marrow transplantationA dated cancer milestone (1990): nobel-recognized work enabling transplants for blood cancers. Why it mattered, its limits, and how the field evolved.
• Lung cancer · 1950Doll and Hill report the link between smoking and lung cancerA dated cancer milestone (1950): landmark epidemiology connecting tobacco to lung cancer. Why it mattered, its limits, and how the field evolved.
• Colorectal cancer · 1988Bert Vogelstein maps a genetic model of colorectal cancerA dated cancer milestone (1988): a stepwise model of how cancer develops through mutations. Why it mattered, its limits, and how the field evolved.
• Breast cancer · 1985Bernard Fisher's trials establish breast-conserving surgeryA dated cancer milestone (1985): evidence that lumpectomy plus radiation can equal mastectomy for many. Why it mattered, its limits, and how the field evolved.
• Childhood cancer · 1971Alfred Knudson proposes the two-hit hypothesisA dated cancer milestone (1971): a model for how inherited and acquired mutations cause cancer. Why it mattered, its limits, and how the field evolved.